Research advances in systemic therapy for hepatocellular carcinoma in the era of precision medicine
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in clinical practice and has the features of high incidence rate, poor prognosis, and high mortality rate, and its incidence rate and mortality rate rank among the top malignant tumors in the world. High heterogeneity of HCC a...
Main Author: | ZHU Guiqi |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2020-10-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=11088 |
Similar Items
-
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
by: Duan J, et al.
Published: (2019-10-01) -
Research advances in traditional Chinese medicine combined with interventional therapy for hepatocellular carcinoma
by: LIU Yang
Published: (2015-01-01) -
Research advances in proton beam therapy for hepatocellular carcinoma
by: DAI Shuyang
Published: (2013-10-01) -
Two predictive precision medicine tools for hepatocellular carcinoma
by: Zhiqiao Zhang, et al.
Published: (2019-11-01) -
Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
by: Caleb R. Dulaney, et al.
Published: (2016-01-01)